The lack of “shared understanding” between technology partners and clinical trialists is slowing progress in delivering the fully integrated, unified digital platforms that are needed to better support the use of decentralized clinical trials (DCTs).
Key Takeaways
-
Researchers on behalf of the EU public-private Trials@Home project have published a paper on the use of digital platform and their role in decentralized clinical trials.
-
The paper notes that many commercially available platform solutions are not yet capable of integrating third-party components or are limited in their service provision and functionalities.
-
Using existing components and already established solutions typically results in a lack of interoperability, dependence on functionalities, and vendor lock-in
This was the message from a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?